Paul Perreault has over 35 years of experience across the global biotech and pharmaceutical industries.
Prior to becoming chief executive and managing director of CSL in July 2013, he spent more than 15 years in key senior roles at Wyeth-Ayerst Laboratories (now part of Pfizer).
Mr Perreault holds a Bachelors degree in Psychology from the University of Central Florida, and completed Advanced Business Management training at the Kellogg and Wharton Schools of Business.